Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function
Lingyue Gao, Zhuo‐Xun Wu, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2021) Vol. 57, pp. 100770-100770
Closed Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Anticancer drug resistance: An update and perspective
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Drug Resistance Updates (2021) Vol. 59, pp. 100796-100796
Open Access | Times Cited: 239
Novel nanomedicines to overcome cancer multidrug resistance
Zhenwei Su, Shaowei Dong, Shan‐Chao Zhao, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100777-100777
Closed Access | Times Cited: 134
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Roberto Mattioli, Andrea Ilari, Beatrice Colotti, et al.
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101205-101205
Open Access | Times Cited: 103
The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells
Cristina P. R. Xavier, Dimas Carolina Belisario, Rita Rebelo, et al.
Drug Resistance Updates (2022) Vol. 62, pp. 100833-100833
Open Access | Times Cited: 57
Single‐Cell Quantification of a Highly Biocompatible Dinuclear Iridium(III) Complex for Photocatalytic Cancer Therapy
Zhongxian Fan, Yi Rong, Tumpa Sadhukhan, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 23
Closed Access | Times Cited: 52
Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis
Longfei Yang, Yuwei Zhang, Yang Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 48
An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer
Wenjing Wang, Jianmin Wang, Shuai Liu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 42
Amphiphilic Dendrimer Doping Enhanced pH‐Sensitivity of Liposomal Vesicle for Effective Co‐delivery toward Synergistic Ferroptosis–Apoptosis Therapy of Hepatocellular Carcinoma
Yanhong Su, Zhao Zhang, Leo Tsz On Lee, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 6
Open Access | Times Cited: 31
mRNA-Based Therapeutics in Cancer Treatment
Han Sun, Yu Zhang, Ge Wang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 622-622
Open Access | Times Cited: 29
Lantern-shaped flexible RNA origami for Smad4 mRNA delivery and growth suppression of colorectal cancer
Muren Hu, Chang Feng, Qianqin Yuan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
The most recent progress of baicalein in its anti-neoplastic effects and mechanisms
Chenjing Lei, Yaya Yu, Yanjuan Zhu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116862-116862
Open Access | Times Cited: 10
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy
Magdalena Jurczyk, Janusz Kasperczyk, Dorota Wrześniok, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1187-1187
Open Access | Times Cited: 34
Epigenetic enzyme mutations as mediators of anti-cancer drug resistance
Sihong Chen, Yingxi Zhao, Shougeng Liu, et al.
Drug Resistance Updates (2022) Vol. 61, pp. 100821-100821
Closed Access | Times Cited: 32
Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer
Beatriz Bueschbell, Ana B. Caniceiro, Pedro M. S. Suzano, et al.
Drug Resistance Updates (2022) Vol. 60, pp. 100811-100811
Open Access | Times Cited: 27
The Biological Roles and Molecular Mechanisms of Long Non-Coding RNA MEG3 in the Hallmarks of Cancer
Lei Zhang, Fuqiang Zhao, Wenfang Li, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6032-6032
Open Access | Times Cited: 27
Sirtuin1-p53: A potential axis for cancer therapy
Jiayi Yin, Xin-Tong Lu, Meng-Ling Hou, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115543-115543
Closed Access | Times Cited: 16
Drug resistance related genes in lung adenocarcinoma predict patient prognosis and influence the tumor microenvironment
Hui Yu, Wenting Zhang, Xian Rong Xu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Investigating POU3F4 in Cancer: Expression Patterns, Prognostic Implications, and Functional Roles in Tumor Immunity
Weiwei Chen, Yaya Ji, Rui Wang, et al.
Heliyon (2025) Vol. 11, Iss. 1, pp. e41587-e41587
Open Access
Anti-tumor role and molecular mechanism of vanillic acid
Xingan Hao, Zhixiao Gao, Mingzhe Hu
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
A review on polysaccharide-based tumor targeted drug nanodelivery systems
Liangxing Tu, Banghuai Xing, Shenglin Ma, et al.
International Journal of Biological Macromolecules (2025), pp. 140820-140820
Closed Access
Biological Applications of Acacia Gums (AGs) SME on Breast Cancer Cell Lines
Ahmed A. M. Elnour, Abdurahmani Hamid Nour, Aiman A. Bin Mokaizh, et al.
(2025), pp. 283-306
Closed Access
Single-Cell RNA Sequencing in Unraveling Acquired Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: New Perspectives
Peng Lin, Siyou Deng, Jinjie Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1483-1483
Open Access
A CRISPR-edited isoform of the AMPK kinase LKB1 improves the response to cisplatin in A549 lung cancer cells
Matheus Brandemarte Severino, Ana Paula Morelli, Isadora Carolina Betim Pavan, et al.
Journal of Biological Chemistry (2025), pp. 108308-108308
Open Access
Overexpressed NEK2 contributes to progression and cisplatin resistance through activating the Wnt/β-catenin signaling pathway in cervical cancer
Haiye Jiang, Wang Xiangzhu, Yunfei Zhang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top